Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 103483
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.103483
Table 6 Pathological characteristics by analgesic use duration after esophagectomy, n (%)
Pathological characteristic
Short-term analgesic use (n = 149)
Long-term analgesic use (n = 229)
t value or χ²
P value
TNM stage1.900.17
I or II stage78 (52.35)88 (38.43)
III or IV stage71 (47.65)141 (61.57)
Tumor location0.160.92
Upper segment29 (19.46)43 (18.78)
Middle segment77 (51.68)121 (52.84)
Lower segment43 (28.86)65 (28.38)
Tumor diameter1.400.24
< 3 cm74 (49.66)81 (35.37)
≥ 3 cm75 (50.34)148 (64.63)
Depth of tumor infiltration1.130.29
On the muscle layer65 (43.62)78 (34.06)
Subcutaneous muscle layer84 (56.38)151 (65.94)
Histological differentiation2.740.26
Well differentiated42 (28.19)47 (20.52)
Moderately differentiated81 (54.36)115 (50.22)
Poorly differentiated26 (17.45)67 (29.26)
Perineural invasion1.490.22
No124 (83.22)162 (70.74)
Yes25 (16.78)67 (29.26)
Tumor thrombus1.220.27
No125 (83.89)176 (76.86)
Yes24 (16.11)53 (23.14)
Lymph node metastasis1.900.17
No86 (57.72)98 (42.79)
Yes63 (42.28)131 (57.21)